Results 211 to 220 of about 22,335 (252)
Some of the next articles are maybe not open access.
Lipid droplets in steatotic liver disease
Current Opinion in Clinical Nutrition & Metabolic Care, 2023Purpose of review This review aims to discuss the most recent evidence exploring the role of lipid droplets in steatotic liver disease (SLD). We highlight the breadth of mechanisms by which lipid droplets may contribute to the progression of SLD with a particular focus on the role of lipid droplets as inducers of mechanical ...
Josh, Bilson, Eleonora, Scorletti
openaire +2 more sources
Screening for advanced steatotic liver disease
The Lancet Gastroenterology & HepatologySteatotic liver disease often progresses asymptomatically, with the risk of advancing to cirrhosis and liver cancer. Early detection of advanced liver disease through screening presents an opportunity to prevent severe outcomes, if said screening is linked to effective intervention.
Johansen, Stine; id_orcid 0000-0002-5031-2294 +3 more
openaire +4 more sources
Clinical Gastroenterology and Hepatology
The terminology and definition of fatty liver disease has evolved significantly. Recently, the overarching term of steatotic liver disease (SLD) has been endorsed by international societies.1,2 SLD further encompasses individuals with cardiometabolic risk factors (CMRFs), namely, metabolic dysfunction-associated steatotic liver disease (MASLD).
Ming-Lung Yu +2 more
exaly +3 more sources
The terminology and definition of fatty liver disease has evolved significantly. Recently, the overarching term of steatotic liver disease (SLD) has been endorsed by international societies.1,2 SLD further encompasses individuals with cardiometabolic risk factors (CMRFs), namely, metabolic dysfunction-associated steatotic liver disease (MASLD).
Ming-Lung Yu +2 more
exaly +3 more sources
Role of steatotic liver disease in prediction and prevention of cardiometabolic diseases
Nature Reviews Gastroenterology & Hepatology, 2023Steatotic liver disease has emerged as an important risk factor for cardiovascular disease, type 2 diabetes mellitus and chronic kidney disease. Successful treatment of steatotic liver disease might also be effective in preventing these cardiometabolic diseases.
Norbert Stefan +2 more
openaire +3 more sources
Steatotic liver disease after pediatric liver transplantation
Liver TransplantationMetabolic dysfunction–associated steatotic liver disease is becoming an increasingly frequent cause of chronic liver disease in children. It has been reported as a complication of liver transplantation in adults but remains poorly evaluated in liver-transplanted children.
Wischlen, Emma +9 more
openaire +2 more sources
Role of Neutrophils in the Development of Steatotic Liver Disease
Seminars in Liver DiseaseThis review explores the biological aspects of neutrophils, their contributions to the development of steatotic liver disease, and their potential as therapeutic targets for the disease. Although alcohol-associated and metabolic dysfunction-associated liver diseases originate from distinct etiological factors, the two diseases frequently share ...
You-Jin, Choi +2 more
openaire +2 more sources
Steatotic Liver Disease: Pathophysiology and Emerging Pharmacotherapies
Pharmacological ReviewsSteatotic liver disease (SLD) displays a dynamic and complex disease phenotype. Consequently, the metabolic dysfunction-associated steatotic liver disease (MASLD)/metabolic dysfunction-associated steatohepatitis (MASH) therapeutic pipeline is expanding rapidly and in multiple directions.
Michail Kokkorakis +6 more
openaire +2 more sources
Editorial: Crystalising the burden of steatotic liver disease
Alimentary Pharmacology & TherapeuticsLINKED CONTENTThis article is linked to Schneider et al papers.
Luis Calzadilla Bertot, Leon A. Adams
openaire +2 more sources
Steatotic Liver Diseases (SLDs): A Review
Journal of Insurance MedicineLiver steatosis is now the politically correct term for excessive fat in the liver (fatty liver). Its incidence and prevalence, in lockstep with diabetes and obesity, continue to climb to over 2 billion persons worldwide. It is the most common cause of chronic liver disease and the leading cause of liver-related morbidity and mortality. This treatise,
openaire +2 more sources
Steatotic liver disease and HIV: an agenda for 2030
The Lancet HIVPeople living with HIV are particularly susceptible to developing metabolic disorders, including metabolic dysfunction-associated steatotic liver disease and other forms of SLD. However, people living with HIV have been historically excluded from clinical trials and large cohort studies of SLD.
Pericàs, Juan M +12 more
openaire +2 more sources